Browsing by Author Chan, SYT

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 8 to 21 of 21 < previous 
TitleAuthor(s)Issue DateViews
 
Long-term Follow-up of Cytomegalovirus Retinitis in Non-HIV Immunocompromised Patients: Clinical Features and Visual Prognosis
Journal:American Journal of Ophthalmology
Iu, LPLFan, CYLau, KPChan, SYTKwong, YLWong, YHI
2016
24
 
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study
Journal:Cancer
Singh, GHHYim, RLHLee, HKKMak, VLin, SYKho, BYip, SFLau, JSMLi, WIp, HWHwang, YYGChan, SYTTse, EWCAu, WYKumana, CRKwong, YL
2018
107
 
Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity
Journal:Annals of Hematology
Chan, SYTLuk, THLau, JSKhong, PLKwong, YL
2017
57
 
Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
Journal:Cancer
Singh, GHHKumana, CRYim, RLHHwang, YYGChan, SYTYip, SFLee, HKKMak, VLau, JSMChan, CCKho, BWong, RSMLi, WLin, SYLau, CKIp, HWLeung, RYYLam, CCKKwong, YL
2019
47
 
PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing l-asparaginase: efficacy and safety
Journal:Annals of Hematology
Chan, SYTLi, JLoong, FKhong, PLTse, EWCKwong, YL
2017
54
 
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase
Journal:Blood
Kwong, YLChan, SYTTan, DKim, SJPoon, LMMow, BKhong, PLLoong, FAu Yeung, KHRIqbal, JPhipps, CTse, EWC
2017
38
 
Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma
Journal:Annals of Hematology
Chan, SYTKhong, PLKwong, YL
2016
52
 
Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
Journal:Annals of Hematology
Chan, SYTKhong, PLKwong, YL
2016
32
 
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital
Journal:Journal of Medical Economics
Chan, SYTMarcella, SWSingh, GHHHwang, YYGKwong, YL
2016
49
 
Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma
Journal:Hematology
Chan, SYTLee, EYPKhong, PLTse, EWCKwong, YL
2018
69
 
A staged approach with vincristine, adriamycin and dexamethasone followed by bortezomib, thalidomide and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma
Journal:Annals of Hematology
Chim, CSLie, AKWChan, EYTLeung, YYCheung, SCWChan, SYTLiang, RKwong, YL
2010
129
 
A staged approach with vincristine, adriamycin and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma
Proceeding/Conference:Haematologica
Chim, CSLie, AKWChan, EYTLeung, YYCheung, SCWChan, SYTLiang, RKwong, YL
2010
102
 
Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus–positive plasma cell myeloma
Journal:Annals of Hematology
Chan, SYTIp, HWAu Yeung, KHRPang, AWKKwong, YL
2020
 
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
Journal:Leukemia
Lim, JQHuang, DTang, TTan, DLaurensia, YPeng, RJWong, EKYCheah, DMZChia, BKHIqbal, JGrigoropoulos, NFNairismägi, MLNg, CCYRajasegaran, VHong, HKim, SJCho, JTse, EWCMow, BCai, QCPoon, LMCai, QQTan, JChan, JYLim, JXGoh, YTPhipps, CRötzschke, OCheng, CLHa, JCHKhoo, LPLoh, YSMAu Yeung, KHRChan, SYTKwong, YLHwang, WKim, WSBei, JXLin, TOng, CKLim, ST
2020
Showing results 8 to 21 of 21 < previous